Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 8
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Laupland, K.B. 2013. Incidence of bloodstream infection: a review of population-based studies. Clinical Microbiology and Infection, Vol. 19, Issue. 6, p. 492.

    McIntosh, E David G and Reinert, Ralf R 2011. Global prevailing and emerging pediatric pneumococcal serotypes. Expert Review of Vaccines, Vol. 10, Issue. 1, p. 109.

    Zemlickova, H. Jakubu, V. Urbaskova, P. Motlova, J. Musilek, M. and Adamkova, V. 2010. Serotype-specific invasive disease potential of Streptococcus pneumoniae in Czech children. Journal of Medical Microbiology, Vol. 59, Issue. 9, p. 1079.

    Prymula, R. Chlibek, R. Ivaskeviciene, I. Mangarov, A. Mészner, Zs. Perenovska, P. Richter, D. Salman, N. Šimurka, P. Tamm, E. Tešović, G. Urbancikova, I. and Usonis, V. 2011. Paediatric pneumococcal disease in Central Europe. European Journal of Clinical Microbiology & Infectious Diseases, Vol. 30, Issue. 11, p. 1311.

    Žemličková, Helena Urbášková, Pavla Jakubů, Vladislav Motlová, Jitka Musílek, Martin and Procházka, Bohumír 2010. Clonal Distribution of Invasive Pneumococci, Czech Republic, 1996–2003. Emerging Infectious Diseases, Vol. 16, Issue. 2, p. 287.

    Grabenstein, J. D. and Weber, D. J. 2014. Pneumococcal Serotype Diversity Among Adults in Various Countries, Influenced by Pediatric Pneumococcal Vaccination Uptake. Clinical Infectious Diseases, Vol. 58, Issue. 6, p. 854.

    Laupland, Kevin B. and Church, Deirdre L. 2014. Population-Based Epidemiology and Microbiology of Community-Onset Bloodstream Infections. Clinical Microbiology Reviews, Vol. 27, Issue. 4, p. 647.

    Rueda, Adriana M. Serpa, José A. Matloobi, Mahsa Mushtaq, Mahwish and Musher, Daniel M. 2010. The Spectrum of Invasive Pneumococcal Disease at an Adult Tertiary Care Hospital in the Early 21st Century. Medicine, Vol. 89, Issue. 5, p. 331.


Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997–2006

  • J. MOTLOVA (a1) (a2), C. BENES (a3) and P. KRIZ (a2)
  • DOI:
  • Published online: 16 September 2008

We studied the incidence of invasive pneumococcal disease (IPD) in the Czech Republic by analysing two sources of data. The incidence of pneumococcal meningitis based on routine notification data varied between 0·4 and 0·6/100 000 population between 1997 and 2006. The incidence of IPD based on laboratory surveillance varied between 2·3 and 4·3/100 000 population between 2000 and 2006. The annual IPD incidence remained stable during the study period. Estimates of absolute IPD case-load in the entire country varied from 235 to 437 per year. The age-specific incidence was highest in the <1 year age group, reaching 4·3/100 000 for pneumococcal meningitis in routine notification and 15·7/100 000 for IPD in laboratory-based surveillance data, respectively. A total of 1236 Streptococcus pneumoniae isolates from cerebrospinal fluid and sterile body sites were investigated. The most frequent serotypes causing IPD in all ages were 3, 4, 14, 8 and 19F, accounting for 41·5% of all isolates. The most frequent serotypes by age group were: <1 year (6B and 19F); 1–4 years (14, 6B and 23F); 40–64 years (3, 8 and 4), and ⩾65 years (3, 4, 9N and 14). The coverage of serotypes in all age groups by pneumococcal vaccines ranged from 41·5% for 7-valent conjugate vaccine to 67·9% for 13-valent conjugate vaccine. The coverage of serotypes causing IPD is significantly different between infants/children and adults/elderly. PCV-7 coverage by age group was: <1 year (66·0%), 1–4 years (65·1%), 40–64 years (34·4%) and ⩾65 years (39·3%). Similar age differences between infants/children and adults/elderly were found in coverage by PCV-9, PCV-11 and PCV-13. The distribution of serotypes in the total population and individual age groups was stable during the period 2000–2006.

Corresponding author
*Author for correspondence: Dr P. Kriz, WHO Collaborating Centre for Reference and Research on Streptococci, National Institute of Public Health, Srobarova 48, 100 42 Prague 10, Czech Republic. (Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1.CG Whitney , Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006; 368: 14951502.

2.JD Kellner , Progress in the prevention of pneumococcal infection. Canadian Medical Association Journal 2005; 173: 11491151.

3.JRG Butler , The cost-effectiveness of pneumococcal conjugate vaccination in Australia. Vaccine 2004; 22: 11381149.

6.CG Grijalva , Decline in pneumonia admission after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007; 369: 11791186.

8.A Vergison , Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough. Pediatrics 2006; 118: 801809.

9.R Dagan , Epidemiology of invasive childhood pneumococcal infections in Israel. Journal of the American Medical Association 1992; 268: 33283332.

10.L Spanjaard , Epidemiology of meningitis and bacteremia due to Streptococcus pneumoniae in The Netherlands. Acta Paediatrica (Suppl.) 2000; 89: 2226.

11.R Von Kries , Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clinical Infectious Diseases 2000; 31: 482487.

12.E Miller , Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996–1998. Acta Paediatrica (Suppl.) 2000; 89: 1116.

15.J Escola , Epidemiology of invasive pneumococcal infections in children in Finland. Journal of the American Medical Association 1992; 268: 33233327.

16.I Venetz , K Schopfer , K Muhlemann . Paediatric invasive pneumococcal disease in Switzerland, 1985–1994. International Journal of Epidemiology 1998; 27: 11011104.

17.P Ispahani , Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation. Archives of Disease in Childhood 2004; 89: 757762.

18.MS Kaltoft , N Zeuthen , HB Konradsen . Epidemiology of invasive pneumococcal infections in children aged 0–6 years in Denmark: a 19-year nationwide surveillance study. Acta Paediatrica (Suppl.) 2000; 89: 310.

19.WP Hausdorff . Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution. European Journal of Pediatrics 2002; 161: 135139.

20.F D'Ancona , Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy. Vaccine 2005; 23: 24942500.

21.WP Hausdorff , Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use. Part 1. Clinical Infectious Diseases 2000; 30: 100121.

23.KL O'Brien , R Dagan . The potential indirect effect of conjugate pneumococcal vaccines. Vaccine 2003; 21: 18151825.

25.I Serrano , Invasive Streptococcus pneumoniae from Portugal: implications for vaccination and antimicrobial therapy. Clinical Microbiology and Infection 2004; 10: 652656.

26.R Von Kries , Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children. Pediatric Infectious Disease Journal 2002; 21: 10171023.

28.LL Hammitt , Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. Journal of Infectious Diseases 2006; 193: 14871494.

29.DJ Isaacman , Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar). Vaccine 2007; 25: 24202427.

30.CL Byington , Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the Intermountain West: emergence of nonvaccine serogroups. Clinical Infectious Diseases 2005; 41: 2129.

31.BE Gonzalez , Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatric Infectious Disease Journal 2006; 25: 301305.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *